Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone replacement after traumatic brain injury with severe adult growth hormone deficiency
2010-019735-35Phase 4Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in growth hormone deficiency (GHD) and hypopituitarism, sponsored by CHU Amiens-Picardie. Primary endpoint: Body composition and bone mineral content by DEXA. Started Apr 2010; status: active.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)hypopituitarism
Beyond the preview
Go deeper on 2010-019735-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019735-35.